Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07706374 Exemestane Polyendocrine Metabolic Ovarian Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07706374 clinical trial report covering Exemestane, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262753 KN-5501 Scleroderma, Systemic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262753 clinical trial report covering KN-5501, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262524 HS-10506 Sleep Initiation and Maintenance Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262524 clinical trial report covering HS-10506, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07709637 LB-DTK-COV19 COVID-19 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07709637 clinical trial report covering LB-DTK-COV19, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262749 Lansoprazole/Sodium Bicarbonate Esophagitis, Peptic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262749 clinical trial report covering Lansoprazole/Sodium Bicarbonate, Phase 1, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
ChiCTR2600128259 ZX2021 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600128259 clinical trial report covering ZX2021, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708116 CTX-187 Bronchiectasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708116 clinical trial report covering CTX-187, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708428 LG-0317 Herpesviridae Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708428 clinical trial report covering LG-0317, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07706686 rDEN2delta30-7169 vaccine(National Institute of Allergy & Infectious Diseases) Dengue Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07706686 clinical trial report covering rDEN2delta30-7169 vaccine(National Institute of Allergy & Infectious Diseases), Phase 1, endpoints, sponsor, geo
Latest Hotspot
8 min read
NCT07708493 BI-3034701 Overweight Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708493 clinical trial report covering BI-3034701, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708272 Rovadicitinib Myelofibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708272 clinical trial report covering Rovadicitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07708038 Tocilizumab Kidney Failure, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07708038 clinical trial report covering Tocilizumab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.